참고문헌 (21)

1. 1 Harris NL Jaffe ES Diebold J Flandrin G Muller-Hermelink HK Vardiman J Lister TA Bloomfield CD The World Health Organization classification of neoplasms of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting--Airlie House, Virginia, November, 1997 Hematol J 2000 1 53 66 11920170 

2. 2 Ko YH Kim CW Park CS Jang HK Lee SS Kim SH Ree HJ Lee JD Kim SW Huh JR REAL classification of malignant lymphomas in the Republic of Korea: incidence of recently recognized entities and changes in clinicopathologic features. Hematolymphoreticular Study Group of the Korean Society of Pathologists. Revised European-American lymphoma Cancer 1998 83 806 812 9708949 

3. 3 Armitage JO Weisenburger DD New approach to classifying non-Hodgkin's lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin's Lymphoma Classification Project J Clin Oncol 1998 16 2780 2795 9704731 

   상세보기

4. 4 Yamaguchi M Ohno T Oka K Taniguchi M Ito M Kita K Shiku H De novo CD5-positive diffuse large B-cell lymphoma: clinical characteristics and therapeutic outcome Br J Haematol 1999 105 1133 1139 10554834 

   상세보기

5. 5 Yamaguchi M Seto M Okamoto M Ichinohasama R Nakamura N Yoshino T Suzumiya J Murase T Miura I Akasaka T Tamaru J Suzuki R Kagami Y Hirano M Morishima Y Ueda R Shiku H Nakamura S De novo CD5+ diffuse large B-cell lymphoma: a clinicopathologic study of 109 patients Blood 2002 99 815 821 11806981 

   상세보기

6. 6 Matolcsy A Chadburn A Knowles DM De novo CD5-positive and Richter's syndrome-associated diffuse large B cell lymphomas are genotypically distinct Am J Pathol 1995 147 207 216 7541611 

   상세보기

7. 7 Pileri SA Dirnhofer S Went P Ascani S Sabattini E Marafioti T Tzankov A Leoncini L Falini B Zinzani PL Diffuse large B-cell lymphoma: one or more entities? Present controversies and possible tools for its subclassification Histopathology 2002 41 482 509 12460202 

   상세보기

8. 8 Katzenberger T Lohr A Schwarz S Dreyling M Schoof J Nickenig C Stilgenbauer S Kalla J Ott MM Muller-Hermelink HK Ott G Genetic analysis of de novo CD5+ diffuse large B-cell lymphomas suggests an origin from a somatically mutated CD5+ progenitor B cell Blood 2003 101 699 702 12393524 

   상세보기

9. 9 Colomo L Lopez-Guillermo A Perales M Rives S Martinez A Bosch F Colomer D Falini B Montserrat E Campo E Clinical impact of the differentiation profile assessed by immunophenotyping in patients with diffuse large B-cell lymphoma Blood 2003 101 78 84 12393466 

   상세보기

10. 10 Coiffier B Diffuse large cell lymphoma Curr Opin Oncol 2001 13 325 334 11555708 

    상세보기

11. 11 Harris NL Jaffe ES Diebold J Flandrin G Muller-Hermelink HK Vardiman J Lister TA Bloomfield CD World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997 J Clin Oncol 1999 17 3835 3849 10577857 

    상세보기

12. 12 Mitelman F ISCN 1995: An International System for Human Cytogenetic Nomenclature Basel, Switzerland S. Karger 

13. 13 Cro L Guffanti A Colombi M Cesana B Grimoldi MG Patriarca C Goldaniga M Neri A Intini D Cortelezzi A Maiolo AT Baldini L Diagnostic role and prognostic significance of a simplified immunophenotypic classification of mature B cell chronic lymphoid leukemias Leukemia 2003 17 125 132 12529669 

    상세보기

14. 14 Shipp MA Ross KN Tamayo P Weng AP Kutok JL Aguiar RC Gaasenbeek M Angelo M Reich M Pinkus GS Ray TS Koval MA Last KW Norton A Lister TA Mesirov J Neuberg DS Lander ES Aster JC Golub TR Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning Nat Med 2002 8 68 74 11786909 

    상세보기

15. 15 Rosenwald A Wright G Chan WC Connors JM Campo E Fisher RI Gascoyne RD Muller-Hermelink HK Smeland EB Giltnane JM Hurt EM Zhao H Averett L Yang L Wilson WH Jaffe ES Simon R Klausner RD Powell J Duffey PL Longo DL Greiner TC Weisenburger DD Sanger WG Dave BJ Lynch JC Vose J Armitage JO Montserrat E Lopez-Guillermo A Grogan TM Miller TP Le-Blanc M Ott G Kvaloy S Delabie J Holte H Krajci P Stokke T Staudt LM The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma N Engl J Med 2002 346 1937 1947 12075054 

    상세보기

16. 16 Pospisil R Fitts MG Mage RG CD5 is a potential selecting ligand for B cell surface immunoglobulin framework region sequences J Exp Med 1996 184 1279 1284 8879199 

17. 17 Kobayashi T Yamaguchi M Kim S Morikawa J Ogawa S Ueno S Suh E Dougherty E Shmulevich I Shiku H Zhang W Microarray reveals differences in both tumors and vascular specific gene expression in de novo CD5+ and CD5- diffuse large B-cell lymphomas Cancer Res 2003 63 60 66 12517778 

    상세보기

18. 18 Yin Z Giacomello E Gabriele E Zardi L Aota S Yamada KM Skerlavaji B Doliana R Colombatti A Perris R Cooperative activity of alpha4beta1 and alpha4beta7 integrins in mediating human B-cell lymphoma adhesion and chemotaxis on fibronectin through recognition of multiple synergizing binding sites within the central cell-binding domain Blood 1999 93 1221 1230 9949164 

19. 19 Terol MJ Lopez-Guillermo A Bosch F Villamor N Cid MC Campo E Montserrat E Expression of beta-integrin adhesion molecules in non-Hodgkin's lymphoma: correlation with clinical and evolutive features J Clin Oncol 1999 17 1869 1875 10561227 

    상세보기

20. 20 Corcoran LM Karvelas M Nossal GJ Ye ZS Jacks T Baltimore D Oct-2, although not required for early B-cell development, is critical for later B-cell maturation and for postnatal survival Genes Dev 1993 7 570 582 8096198 

    상세보기

21. 21 Rutella S Rumi C Di Mario A Leone G Expression of thrombospondin receptor (CD36) in chronic B-cell lymphoproliferative disorders: a role in tumor metastasis? Eur J Histochem 1997 41 Suppl 2 2 53 54 9859781